Dayton Children’s Hospital Taps Medline as Laboratory Prime Vendor

Agreement follows company’s supply chain solutions during the pandemic

Medline has been selected as Dayton Children’s Hospital’s laboratory prime vendor, entering into a multi-year agreement; an expansion of an existing partnership. For more than eight years, Medline has provided surgical and medical supplies to Dayton Children’s Hospital.

During the pandemic, Medline expanded its role with Dayton Children’s Hospital, helping the procurement team to improve supply chain and product standardization. Solutions included integrating laboratory supply procurement with the hospital’s broader supply chain operations, providing the hospital with a greater understanding of supply needs and available products, as well as potential product substitutions. As a result, the hospital was able to provide optimal care during the pandemic, as well as laboratory services and testing kits to other area hospitals and community residents.

“Because we were in constant communication with Medline, we were confident in our ability to maintain our supplies while also sharing resources with other hospitals and agencies when needed during the pandemic,” said Jennifer Nichols, laboratory finance manager for Dayton Children’s.

Dayton Children’s Hospital was selected by the State of Ohio to deliver regional laboratory care during the pandemic. The hospital also partnered with the Greater Dayton Area Hospital Association (GDAHA) to provide laboratory equipment and testing kits to various hospitals across nine different counties. In addition, Dayton Children’s Hospital opened three, drive-through COVID-19 testing sites for children and adults, and enacted a patient surge plan to care for adult patients when other hospitals did not have available beds.

“Our lab team truly went above and beyond to make sure we could provide all the testing our patients needed, as well as offer testing resources to the community as a whole,” said Melanie Wilson, senior director of laboratory services and medical imaging for Dayton Children’s.

“The keys to navigating these tough times were collaboration and communication,” said Wilson. “Through it all, our supply chain never let us down.”

 Learn more about Medline’s laboratory solutions.

SourceMedline

Hot this week

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed™ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.